BioEcho Life Sciences announces expansion with new US subsidiary!
BioEcho Life Sciences, a Germany-based biotechnology company supplying the fastest and most sustainable nucleic acid extraction technology, announces the opening of its US subsidiary in Boston, MA.
About BioEcho Life Sciences
BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market - in just one single step. It reduces the associated plastic consumption by up to 70 %.
BioEcho was founded in 2016 by leading industry experts. The headquarter in Cologne, Germany, is certified according to ISO 9001 and ISO 13485.
Press contact:
Christiane Schlottbom
Director Marketing
Office: +49 221 998897-42
E-Mail: christiane.schlottbom@bioecho.de